Evidence map›Paper›PMID 24914408›Full record

ArticleMedChemComm2014

Development of CBAP-BPyne, a probe for γ-secretase and presenilinase.

Natalya Gertsik, T Eric Ballard, Christopher W Am Ende, Douglas S Johnson, Yue-Ming Li

Open access · greenAbstract read
In one paragraph

Article in MedChemComm, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Structural and Chemical Biology of Presenilin Complexes.Cold Spring Harbor perspectives in medicine · 2017
    Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Natalya GertsikMolecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA ; Biochemistry and Molecular Biology Program, Weill Graduate School of Medical Sciences of Cornell University, New York, NY 10021, USA.
T Eric BallardPfizer Worldwide Research and Development, Neuroscience Medicinal Chemistry and Chemical Biology, Cambridge, MA 02139, USA ; Pfizer Worldwide Research and Development, Neuroscience Medicinal Chemistry, Groton, CT 06340, USA.
Christopher W Am EndePfizer Worldwide Research and Development, Neuroscience Medicinal Chemistry, Groton, CT 06340, USA.
Douglas S JohnsonPfizer Worldwide Research and Development, Neuroscience Medicinal Chemistry and Chemical Biology, Cambridge, MA 02139, USA.
Yue-Ming LiMolecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Institute of Medicinal Plant Development · CNCornell University · USMemorial Sloan Kettering Cancer Center · USPfizer (United States) · US

Funding

Regulation and Function of Gamma-SecretaseR01AG026660 · NIA · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI LI, YUEMING · 2005 to 2015
$3.5M
Mechanism and therapy of AB-42-specific gamma-secretaseR01NS076117 · NINDS · SLOAN-KETTERING INST CAN RESEARCH · PI LI, YUEMING, ZHENG, HUI · 2011 to 2015
$2.8M
NIA NIH HHS R01 AG026660NINDS NIH HHS R01 NS076117
6 · The paper itself

Abstract

γ-Secretase undergoes endoproteolysis of its catalytic subunit, presenilin (PS), to form PS N-terminal and C-terminal fragments (PS1-NTF/CTF), which generate the active site. PS endoproteolysis, catalyzed by presenilinase (PSase), remains poorly understood and requires novel chemical approaches for its mechanistic study. CBAP is a dual inhibitor that suppresses both γ-secretase and PSase activities. To probe γ-secretase and PSase activity in cells, we have synthesized the clickable photoaffinity probe CBAP-BPyne. We found that CBAP-BPyne specifically labels PS1-NTF and signal peptide peptidase (SPP). CBAP-BPyne is a valuable tool to directly study the mechanism of endoproteolysis.

Identifiers

PMID24914408
PMCPMC4048150
OpenAlexW2090891117

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.